These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 309809)

  • 1. The immune-dependence of schistosomicidal chemotherapy: relative lack of efficacy of an antimonial in Schistosoma mansoni-infected mice deprived of their T-cells and the demonstration of drug-antiserum synergy.
    Doenhoff MJ; Bain J
    Clin Exp Immunol; 1978 Aug; 33(2):232-8. PubMed ID: 309809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the host-parasite relationship in Schistosoma mansoni-infected mice: the immunological dependence of parasite egg excretion.
    Doenhoff M; Musallam R; Bain J; McGregor A
    Immunology; 1978 Nov; 35(5):771-8. PubMed ID: 309856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1985 Dec; 60(3):348-54. PubMed ID: 3935473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the antibilharzial compound (Bilharcid) on Schistosoma mansoni in vitro and in vivo.
    Mahran SG; Shehata H; Abdulla WA; el-Raziky EH
    Egypt J Bilharz; 1976; 3(2):239-45. PubMed ID: 1037637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response.
    Brindley PJ; Sher A
    J Immunol; 1987 Jul; 139(1):215-20. PubMed ID: 3108397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. I. The acute phase proteins, C3 and serum amyloid P-component (SAP).
    Pepys MB; Baltz ML; Musallam R; Doenhoff MJ
    Immunology; 1980 Feb; 39(2):249-54. PubMed ID: 6966607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary observations on the in vitro lymphocyte transformation from mice infected with Schistosoma mansoni troughout treatment with an antimonial.
    Pérez H; Pérez M; Payares G
    Rev Bras Biol; 1973; 33(4):547-52. PubMed ID: 4548549
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections.
    Doenhoff M; Bickle Q; Bain J; Webbe G; Nelson G
    J Helminthol; 1980 Mar; 54(1):7-16. PubMed ID: 7373025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. II. Immunoglobulin G and antibodies specific for heterologous erythrocytes.
    Musallam R; Bain J; McGregor A; Doenhoff M
    Immunology; 1980 Jul; 40(3):343-52. PubMed ID: 6776032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathological effects of immunosuppression of Schistosoma mansoni-infected mice, with particular reference to survival and hepatotoxicity after thymectomy and treatment with antithymocyte serum, and treatment with hydrocortisone acetate.
    Lucas S; Musallam R; Bain J; Hassounah O; Bickle Q; Doenhoff M
    Trans R Soc Trop Med Hyg; 1980; 74(5):633-43. PubMed ID: 6971004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of macrophage activation and resistance by suppressor T lymphocytes in chronic murine Schistosoma mansoni infection.
    Olds GR; Ellner JJ
    J Immunol; 1984 Nov; 133(5):2720-4. PubMed ID: 6237154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of granulomatous hypersensitivity. VI. T lymphocyte subsets influence mast cell density in liver granulomas of Schistosoma mansoni-infected mice.
    Weinstock JV; Boros DL
    J Immunol; 1983 Aug; 131(2):959-61. PubMed ID: 6602849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological control of hepatotoxicity and parasite egg excretion in Schistosoma mansoni infections: stage specificity of the reactivity of immune serum in T-cell deprived mice.
    Doenhoff MJ; Pearson S; Dunne DW; Bickle Q; Lucas S; Bain J; Musallam R; Hassounah O
    Trans R Soc Trop Med Hyg; 1981; 75(1):41-53. PubMed ID: 6973848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell helper response to antigens of Schistosoma mansoni in CBA mice.
    Ramalho-Pinto FJ; Goldring OL; Smithers SR; Playfair HL
    Clin Exp Immunol; 1976 Nov; 26(2):327-33. PubMed ID: 791552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni egg antigens and hepatocyte damage in infected T cell-deprived mice.
    Dunne DW; Doenhoff MJ
    Contrib Microbiol Immunol; 1983; 7():22-9. PubMed ID: 6600671
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of the immunosuppressive state during Schistosoma mansoni infection.
    Attallah AM; Smith AH; Murrell KD; Fleischer T; Woody J; Vannier WE; Scher I; Ahmed A; Sell KW
    J Immunol; 1979 Apr; 122(4):1413-20. PubMed ID: 312841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary report on some clinical and biochemical observations in patients treated with Bilharcid.
    Faríd F; Moussà AH; Abulfadl AM; El-Raziky EH; Adham I
    Egypt J Bilharz; 1975; 2(1):31-6. PubMed ID: 810341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of artemether on Schistosoma mansoni: dose-efficacy relationship, and changes in worm morphology and histopathology.
    Xiao SH; Guo J; Chollet J; Wu JT; Tanner M; Utzinger J
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):148-53. PubMed ID: 15597709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.